Myelin peroxisomes – Essential organelles for the maintenance of white matter in the nervous system

Nave, 2010, Myelination and the trophic support of long axons, Nat. Rev. Neurosci., 11, 275, 10.1038/nrn2797 Kassmann, 2007, Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes, Nat. Genet., 39, 969, 10.1038/ng2070 Fünfschilling, 2012, Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity, Nature, 485, 517, 10.1038/nature11007 Lee, 2012, Oligodendroglia metabolically support axons and contribute to neurodegeneration, Nature, 487, 443, 10.1038/nature11314 Brown, 2012, Schwann cell glycogen selectively supports myelinated axon function, Ann. Neurol., 72, 406, 10.1002/ana.23607 Bjartmar, 2001, Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences, Curr. Opin. Neurol., 14, 271, 10.1097/00019052-200106000-00003 Bradl, 1996, Animal models of demyelination, Brain Pathol., 6, 303, 10.1111/j.1750-3639.1996.tb00857.x Mosser, 1993, Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters, Nature, 361, 726, 10.1038/361726a0 Powers, 1997, Peroxisomal disorders: genotype, phenotype, major neuropathologic lesions, and pathogenesis, Brain Pathol., 8, 101, 10.1111/j.1750-3639.1998.tb00139.x Bonekamp, 2009, Reactive oxygen species and peroxisomes: struggling for balance, Biofactors, 35, 346, 10.1002/biof.48 Heiland, 2005, Biogenesis of peroxisomes, FEBS J., 272, 2362, 10.1111/j.1742-4658.2005.04690.x Fransen, 2012, Peroxisome dynamics: molecular players, mechanisms, and (dys)functions, ISRN Cell Biol., 2012, 1, 10.5402/2012/714192 Wanders, 2006, Biochemistry of mammalian peroxisomes revisited, Annu. Rev. Biochem., 75, 295, 10.1146/annurev.biochem.74.082803.133329 Diczfalusy, 1994, Beta-oxidation of eicosanoids, Prog. Lipid Res., 33, 403, 10.1016/0163-7827(94)90025-6 Braverman, 2012, Functions of plasmalogen lipids in health and disease, Biochim. Biophys. Acta, 1822, 1442, 10.1016/j.bbadis.2012.05.008 Saher, 2011, Cholesterol: a novel regulatory role in myelin formation, the neuroscientist: a review journal bringing neurobiology, Neurol. Psychiatr., 17, 79 Hogenboom, 2003, Cholesterol biosynthesis is not defective in peroxisome biogenesis defective fibroblasts, Mol. Genet. Metab., 80, 290, 10.1016/S1096-7192(03)00143-4 Kovacs, 2002, Central role of peroxisomes in isoprenoid biosynthesis, Prog. Lipid Res., 41, 369, 10.1016/S0163-7827(02)00002-4 O'Brien, 1965, Stability of the myelin membrane, Science, 147, 1099, 10.1126/science.147.3662.1099 Norton, 1973, Myelination in rat brain: changes in myelin composition during brain maturation, J. Neurochem., 21, 759, 10.1111/j.1471-4159.1973.tb07520.x Hruban, 1969, Microbodies and related particles. Morphology, biochemistry, and physiology, Int. Rev. Cytol., 1 Holtzman, 1973, Notes on synaptic vesicles and related structures, endoplasmic reticulum, lysosomes and peroxisomes in nervous tissue and the adrenal medulla, J. Histochem. Cytochem., 21, 349, 10.1177/21.4.349 Arnold, 1978, Microperoxisomes in the central nervous system of the postnatal rat, Brain Res., 155, 1, 10.1016/0006-8993(78)90300-1 Adamo, 1986, A possible relationship between concentration of microperoxisomes and myelination, Int. J. Dev. Neurosci., 4, 513, 10.1016/0736-5748(86)90003-1 Mckenna, 1976, Microperoxisome distribution in the central nervous system of the rat, Brain Res., 117, 181, 10.1016/0006-8993(76)90729-0 Kassmann, 2011, A role for myelin-associated peroxisomes in maintaining paranodal loops and axonal integrity, FEBS Lett., 585, 2205, 10.1016/j.febslet.2011.05.032 Ahlemeyer, 2007, Differential expression of peroxisomal matrix and membrane proteins during postnatal development of mouse brain, J. Comp. Neurol., 505, 1, 10.1002/cne.21448 Bradke, 1997, Neuronal polarity: vectorial cytoplasmic flow precedes axon formation, Neuron, 19, 1175, 10.1016/S0896-6273(00)80410-9 Ishikawa, 2001, Peroxisomes exist in growth cones and move anterogradely and retrogradely in neurites of PC12D cells, Exp. Cell Res., 266, 260, 10.1006/excr.2001.5226 Stamer, 2002, Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress, J. Cell Biol., 156, 1051, 10.1083/jcb.200108057 Couchie, 1988, Expression of the mRNA for tau proteins during brain development and in cultured neurons and astroglial cells, J. Neurochem., 50, 1894, 10.1111/j.1471-4159.1988.tb02494.x Binder, 1985, The distribution of tau in the mammalian central nervous system, J. Cell Biol., 101, 1371, 10.1083/jcb.101.4.1371 Braverman, 2013, Peroxisome biogenesis disorders: Biological, clinical and pathophysiological perspectives, Dev. Disabil. Res. Rev., 17, 187, 10.1002/ddrr.1113 Van Roermund, 2008, The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters, FASEB J., 22, 4201, 10.1096/fj.08-110866 Wiesinger, 2013, Impaired very long-chain acyl-CoA-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction, J. Biol. Chem., 288, 19269, 10.1074/jbc.M112.445445 Baes, 2009, Peroxisomes, myelination, and axonal integrity in the CNS, the neuroscientist: a review journal bringing neurobiology, Neurol. Psychiatr., 15, 367 Kemp, 2010, Biochemical aspects of X-linked adrenoleukodystrophy, Brain Pathol., 20, 831, 10.1111/j.1750-3639.2010.00391.x Ferrer, 2010, General aspects and neuropathology of X-linked adrenoleukodystrophy, Brain Pathol., 20, 817, 10.1111/j.1750-3639.2010.00390.x Zgorzalewicz-Stachowiak, 2006, Cerebral childhood and adolescent X-linked adrenoleukodystrophy. Clinical presentation, neurophysiological, neuroimaging and biochemical investigations, Folia Neuropathol., 44, 319 Powers, 1974, Adreno-leukodystrophy (sex-linked Schilder's disease). A pathogenetic hypothesis based on ultrastructural lesions in adrenal cortex, peripheral nerve and testis, Am. J. Pathol., 76, 481 Berger, 2006, X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects, Biochim. Biophys. Acta, 1763, 1721, 10.1016/j.bbamcr.2006.07.010 vanGeel, 1996, Peripheral nerve abnormalities in adrenomyeloneuropathy: a clinical and electrodiagnostic study, Neurology, 46, 112, 10.1212/WNL.46.1.112 van Geel, 1999, Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with “Lorenzo's oil”, J. Neurol. Neurosurg. Psychiatr., 67, 290, 10.1136/jnnp.67.3.290 Powers, 1992, The inflammatory myelinopathy of adreno-leukodystrophy: cells, effector molecules, and pathogenetic implications, J. Neuropathol. Exp. Neurol., 51, 630, 10.1097/00005072-199211000-00007 Ito, 2001, Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation, J. Neuropathol. Exp. Neurol., 60, 1004, 10.1093/jnen/60.10.1004 Kassmann, 2008, Oligodendroglial impact on axonal function and survival – a hypothesis, Curr. Opin. Neurol., 21, 235, 10.1097/WCO.0b013e328300c71f Semmler, 2008, Therapy of X-linked adrenoleukodystrophy, Expert Rev. Neurother., 8, 1367, 10.1586/14737175.8.9.1367 Horvath, 2012, Failure of repeated cyclophosphamide pulse therapy in childhood cerebral X-linked adrenoleukodystrophy, Neuropediatrics, 43, 048, 10.1055/s-0032-1307455 Aubourg, 1990, Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation, N. Engl. J. Med., 322, 1860, 10.1056/NEJM199006283222607 Cartier, 2009, Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy, Science, 326, 818, 10.1126/science.1171242 Asheuer, 2004, Human CD34+ cells differentiate into microglia and express recombinant therapeutic protein, Proc. Natl. Acad. Sci. U. S. A., 101, 3557, 10.1073/pnas.0306431101 Aubourg, 2013, Peroxisomal disorders, Handb. Clin. Neurol., 113, 1593, 10.1016/B978-0-444-59565-2.00028-9 Eichler, 2008, Is microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy?, Ann. Neurol., 63, 729, 10.1002/ana.21391 Bottelbergs, 2011, Peroxisome deficiency but not the defect in ether lipid synthesis causes activation of the innate immune system and axonal loss in the central nervous system, J. Neuroinflammation, 9, 1532 Barth, 2001, Late onset white matter disease in peroxisome biogenesis disorder, Neurology, 57, 1949, 10.1212/WNL.57.11.1949 Forss-Petter, 1997, Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice, J. Neurosci. Res., 50, 829, 10.1002/(SICI)1097-4547(19971201)50:5<829::AID-JNR19>3.0.CO;2-W Lu, 1997, A mouse model for X-linked adrenoleukodystrophy, Proc. Natl. Acad. Sci. U. S. A., 94, 9366, 10.1073/pnas.94.17.9366 Kobayashi, 1997, Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism, Biochem. Biophys. Res. Commun., 232, 631, 10.1006/bbrc.1997.6340 Pujol, 2002, Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy, Hum. Mol. Genet., 11, 499, 10.1093/hmg/11.5.499 Galea, 2012, Oxidative stress underlying axonal degeneration in adrenoleukodystrophy: a paradigm for multifactorial neurodegenerative diseases?, Biochim. Biophys. Acta, 1822, 1475, 10.1016/j.bbadis.2012.02.005 Saher, 2005, High cholesterol level is essential for myelin membrane growth, Nat. Neurosci., 8, 468, 10.1038/nn1426 Bottelbergs, 2010, Axonal integrity in the absence of functional peroxisomes from projection neurons and astrocytes, Glia, 58, 1532, 10.1002/glia.21027 Hulshagen, 2008, Absence of functional peroxisomes from mouse CNS causes dysmyelination and axon degeneration, J. Neurosci., 28, 4015, 10.1523/JNEUROSCI.4968-07.2008 Fan, 1996, Targeted disruption of the peroxisomal fatty acyl-CoA oxidase gene: generation of a mouse model of pseudoneonatal adrenoleukodystrophy, Ann. N. Y. Acad. Sci., 804, 530, 10.1111/j.1749-6632.1996.tb18643.x Ferdinandusse, 2005, Developmental changes of bile acid composition and conjugation in L- and D-bifunctional protein single and double knockout mice, J. Biol. Chem., 280, 18658, 10.1074/jbc.M414311200 Verheijden, 2013, Peroxisomal multifunctional protein-2 deficiency causes neuroinflammation and degeneration of Purkinje cells independent of very long chain fatty acid accumulation, Neurobiol. Dis., 58C, 258, 10.1016/j.nbd.2013.06.006 Kanfer, 1995, Neuroglia, 523 Gatzinsky, 1997, Removal of retrogradely transported material from rat lumbosacral alpha-motor axons by paranodal axon-Schwann cell networks, Glia, 20, 115, 10.1002/(SICI)1098-1136(199706)20:2<115::AID-GLIA3>3.0.CO;2-8 Spencer, 1974, Ultrastructural studies of the dying-back process. II. The sequestration and removal by Schwann cells and oligodendrocytes of organelles from normal and diseases axons, J. Neurocytol., 3, 763, 10.1007/BF01097197 Chakraborty, 2001, Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase, J. Neurochem., 78, 736, 10.1046/j.1471-4159.2001.00456.x Ledeen, 2006, Physiological role of N-acetylaspartate, 131, 10.1007/0-387-30172-0_9 Lin, 2004, The peroxisome deficient Arabidopsis mutant sse1 exhibits impaired fatty acid synthesis, Plant Physiol., 135, 814, 10.1104/pp.103.036772 Asakura, 2006, Multiple contributions of peroxisomal metabolic function to fungal pathogenicity in Colletotrichum lagenarium, Appl. Environ. Microbiol., 72, 6345, 10.1128/AEM.00988-06 Hooks, 2007, The Arabidopsis ALDP protein homologue COMATOSE is instrumental in peroxisomal acetate metabolism, Biochem. J., 406, 399, 10.1042/BJ20070258 Ferreirinha, 2004, Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport, J. Clin. Invest., 113, 231, 10.1172/JCI200420138 Reddy, 2001, Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system, Annu. Rev. Nutr., 21, 193, 10.1146/annurev.nutr.21.1.193 Beller, 2010, Lipid droplets: a dynamic organelle moves into focus, FEBS Lett., 10.1016/j.febslet.2010.03.022 Kohlwein, 2013, Lipid droplets and peroxisomes: key players in cellular lipid homeostasis or a matter of fat-store 'em up or burn 'em down, Genetics, 193, 1, 10.1534/genetics.112.143362 Lamhonwah, 2005, OCTN3 is a mammalian peroxisomal membrane carnitine transporter, Biochem. Biophys. Res. Commun., 338, 1966, 10.1016/j.bbrc.2005.10.170 Lamhonwah, 2008, Expression patterns of the organic cation/carnitine transporter family in adult murine brain, Brain Dev., 30, 31, 10.1016/j.braindev.2007.05.005 Indiveri, 2011, The mitochondrial carnitine/acylcarnitine carrier: function, structure and physiopathology, Mol. Aspects Med., 32, 223, 10.1016/j.mam.2011.10.008 Wawrzeńczyk, 2001, Transport of l-carnitine in isolated cerebral cortex neurons, Eur. J. Biochem., 268, 2091, 10.1046/j.1432-1327.2001.02087.x Verheijen, 2003, Local regulation of fat metabolism in peripheral nerves, Genes Dev., 17, 2450, 10.1101/gad.1116203